CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. 2000

J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
Viral Hepatitis and AIDS Study Group, and Departments of Paediatrics, Radiology, Biochemistry and Immunology, Virgen del Rocío University Hospital, Seville, Spain.

Previous studies have shown a slow recovery of naive CD4+ T cell counts after anti-retroviral therapy in HIV-1-infected adults, which is in accordance with thymus atrophy after puberty. Here we investigate whether or not different patterns of naive CD4+ and CD8+ T cell repopulation are present in adult and child patients undergoing anti-retroviral treatment. Thus, 25 adults under highly active anti-retroviral therapy and 10 children under combined anti-retroviral therapy were retrospectively analysed for T cell subpopulations at baseline (T0) and around week 12 (T1) and week 24 (T2) of anti-retroviral treatment. Mean serum HIV-1 RNA levels dropped in both groups. Recovery of T cells in adults was characterized by a heterogeneous response between patients, with only 44% of them increasing their naive CD4+ and CD8+ T cell counts at T1, and changes in mean total CD4+ T cells were mainly shaped by memory cells. Otherwise, children were characterized by an early increase in naive T cells. Thus, at T1, all children analysed had a strong rise in CD4+ (from 389 +/- 116 to 569 +/- 121 cells/microl; P < 0.01), and nine out of 10 also in naive CD8+ T cells (from 244 +/- 58 to 473 +/- 85 cells/microl; P < 0.05). However, no significant correlation between age and naive repopulation was observed (P = 0. 22) in children. Thus, children had the earlier and greater increases in naive T cell subsets than adults, probably due to a more active thymus, with the potential for immune reconstitution when HIV-1 replication is controlled.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
May 2022, Genomics,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
June 2010, Journal of immunology (Baltimore, Md. : 1950),
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
June 2005, Journal of periodontology,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
December 2000, AIDS patient care and STDs,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
July 2007, Indian journal of pathology & microbiology,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
April 2000, Clinical and experimental immunology,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
January 2021, Computational and structural biotechnology journal,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
June 2012, Journal of medical virology,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
May 2000, Journal of virology,
J M Franco, and J A León-Leal, and M Leal, and A Cano-Rodriguez, and J A Pineda, and J Macías, and A Rubio, and C Rey, and B Sanchez, and E Lissen
July 2000, Nature medicine,
Copied contents to your clipboard!